Chest Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (3)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nakamura, H.
Right arrow Articles by Kato, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nakamura, H.
Right arrow Articles by Kato, H.
(Chest. 2005;128:906-911.)
© 2005 American College of Chest Physicians

Quantitative Detection of Lung Cancer Cells by Fluorescence In Situ Hybridization*

Comparison With Conventional Cytology

Haruhiko Nakamura, MD, PhD; Idiris Aute, MD, PhD; Norihito Kawasaki, MD; Masahiko Taguchi, MD, PhD; Tatsuo Ohira, MD, PhD and Harubumi Kato, MD, PhD, FCCP

* From the Department of Chest Surgery (Drs. Nakamura, Kawasaki, and Taguchi), Atami Hospital, International University of Health and Welfare, Atami, Shizuoka, Japan; the Department of Thoracic Surgery (Dr. Aute), The First Affiliated Hospital, Xinjiang Medical University, Urumqi, People’s Republic of China; and the Department of Surgery (Drs. Ohira and Kato), Tokyo Medical University, Tokyo Japan.

Correspondence to: Haruhiko Nakamura, MD, PhD, Department of Chest Surgery, Atami Hospital, International University of Health and Welfare, 13-1 Higashikaigan-cho, Atami-city, Shizuoka, Japan 413-0012; e-mail: h.nakamura{at}iuhw.ac.jp

Study objective: The aim of this study was to clarify whether fluorescence in situ hybridization (FISH) can diagnose lung cancer in various clinical specimens in comparison with conventional cytology.

Design: Prospective study.

Setting: University hospital in a metropolitan area.

Patients: Fifty consecutive patients with abnormal chest radiography or CT scan findings were enrolled. The patients included 32 men and 18 women, with an average age of 64 years. The final definitive diagnosis was made by histologic examination, as follows: 38 primary lung cancers (24 adenocarcinomas, 8 squamous cell carcinomas, 2 large cell carcinomas, and 4 small cell carcinomas); 1 metastatic renal cell carcinoma; and 11 benign lesions.

Methods: Four types of clinical specimens were analyzed. Cells obtained by transbronchial brushing and transbronchial fine-needle aspiration using a fiberoptic bronchoscope under fluoroscopy, CT scan-guided percutaneous needle biopsy, and bronchial washings. On every examination, duplicate slides were made for analyses of conventional cytology and FISH.

Results: Classifications according to conventional cytology were as follows: class I, 4 patients; class II, 15 patients; class IIIa, 3 patients; class IIIb, 5 patients; and class V, 23 patients. A classification higher than class IIIb was considered to be positive for cancer. For cytology, we found no false-positive cases and 11 false-negative cases. The specificity was 100%, and the sensitivity was 71.8%. By FISH, 34 cases showed aberrant copy numbers in either chromosome 3 or 17. We found no false-positive cases and five false-negative cases. The specificity was 100%, and the sensitivity was 87.1%.

Conclusion: The ability of FISH to detect aneusomic lung cancer cells is superior to conventional cytology for the diagnosis of lung cancer.

Key Words: aneuploidy • aneusomy • cytology • fluorescence in situ hybridization • lung cancer




This article has been cited by other articles:


Home page
ChestHome page
S. Savic, K. Glatz, R. Schoenegg, P. Spieler, G. Feichter, M. Tamm, and L. Bubendorf
Multitarget Fluorescence In Situ Hybridization Elucidates Equivocal Lung Cytology
Chest, June 1, 2006; 129(6): 1629 - 1635.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the American College of Chest Physicians.